SBC Medical Group Holdings Incorporated reported $175M of revenue over the trailing twelve months, −6.9% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $175M (to Q2 2026). Net income: $49M, trailing twelve months to Q2 2026. Free cash flow: $62M, trailing twelve months to Q2 2026. Operating margin: 37%, trailing twelve months to Q2 2026.

SBCSBC Medical Group Holdings Incorporated

Industrials

$5.33+29% 1Y

$5.33

$2.8752 weeks$5.33

SBC as reported

SBC Medical Group Holdings Incorporated reported $175M of revenue over the trailing twelve months, −6.9% on the year before. 11 reported series are charted on this page, each one as filed.

$175M

Revenue, trailing twelve months · to Q2 2026 · −6.9% against the twelve months before

Net income: $49M
Net income · +47% year on year · trailing twelve months to Q2 2026
Free cash flow: $62M
Free cash flow · −702% year on year · trailing twelve months to Q2 2026
Operating margin: 37%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for SBC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$175M	−6.9%	Q2 2026
Net income	$49M	+47%	Q2 2026
EPS	$0.47	+47%	Q2 2026
Gross margin	72%	n/a	Q2 2026
Operating margin	37%	n/a	Q2 2026
Net margin	28%	n/a	Q2 2026
ROE	18%	n/a	Q2 2026
ROA	12%	n/a	Q2 2026
ROIC	39%	n/a	Q2 2026
Free cash flow	$62M	−702%	Q2 2026
P/E	11.3	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.